Trustees of Indiana University was awarded a $7.8 million project grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop pharmacotherapies for the treatment of hydrocephalus and associated conditions from September 1, 2023 through August 31, 2027. Under this award, Indiana University will leverage its expertise in biomedical research to investigate medical solutions targeted toward the military health system. Specifically, the university will conduct applied research toward developing new drug therapies for hydrocephalus, a neurological condition characterized by the abnormal buildup of cerebrospinal fluid in the brain that can cause headaches, vision problems, and cognitive delays if left untreated. By advancing pharmacotherapies for hydrocephalus and related issues, this federally funded research aims to transform healthcare for service members and the general public.
Generated 1/23/24, 7:38 AM